Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of co.don chondrosphere in large knee cartilage defects
2009-016816-20Phase 2Completed
- Sponsor
- CO.DON GmbH
- Start
- Nov 2009
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Condrosphere in cartilage defect, Knee Osteochondral Defect (OCD) and meniscal tear (3 arms), sponsored by CO.DON GmbH. Primary endpoint: Change in overall KOOS at 12 months. Started Nov 2009; status: completed.
02
Drugs
Condrosphere
03
Conditions
cartilage defectKnee Osteochondral Defect (OCD)meniscal tear
Beyond the preview
Go deeper on 2009-016816-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016816-20.